Cargando…
Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma
Background: Hepatocellular carcinoma (HCC) accounts for more than 75% of primary liver cancers, which are the second leading cause of cancer-related deaths. The GALAD (gender, age, AFP-L3, AFP, and des-carboxy-prothrombin) score is a diagnostic tool developed based on gender, age, alpha-fetoprotein,...
Autores principales: | Cagnin, Silvia, Donghia, Rossella, Martini, Andrea, Pesole, Pasqua Letizia, Coletta, Sergio, Shahini, Endrit, Boninsegna, Giulia, Biasiolo, Alessandra, Pontisso, Patrizia, Giannelli, Gianluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671761/ https://www.ncbi.nlm.nih.gov/pubmed/38003675 http://dx.doi.org/10.3390/ijms242216485 |
Ejemplares similares
-
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study
por: Villa, Erica, et al.
Publicado: (2023) -
The Replacement of Only One Portion of Starchy Carbohydrates with Green Leafy Vegetables Regresses Mid and Advanced Stages of NAFLD: Results from a Prospective Pilot Study
por: De Nucci, Sara, et al.
Publicado: (2023) -
Food Network Analysis in Non-Obese Patients with or without Steatosis
por: Donghia, Rossella, et al.
Publicado: (2023) -
Age-Related Dietary Habits and Blood Biochemical Parameters in Patients with and without Steatosis—MICOL Cohort
por: Donghia, Rossella, et al.
Publicado: (2023) -
Contribution of macro- and micronutrients intake to gastrointestinal cancer mortality in the ONCONUT cohort: Classical vs. modern approaches
por: Donghia, Rossella, et al.
Publicado: (2023)